Presentation is loading. Please wait.

Presentation is loading. Please wait.

Therapeutic Agents in Phase I Clinical Trials for Alzheimer’s Disease

Similar presentations


Presentation on theme: "Therapeutic Agents in Phase I Clinical Trials for Alzheimer’s Disease"— Presentation transcript:

1 Therapeutic Agents in Phase I Clinical Trials for Alzheimer’s Disease
ABT-957 ABvac42 AD-SVF (stem cells) Aducanumab Allopregnanolone AstroStem (stem cells) BI BIIB076 Bisnorcymserine (BNC) Bosutinib CB-AC-02 (stem cells) Crenezumab CT1812 Elderberry Juice Escitalopram Growth hormone releasing hormone Insulin aspart IONIS MAPTRx Ketogenic medium chain triglyceride drink KHK6640 LM11A-31-BHS LMSC (stem cells) Lu AF20513 LY LY NeuroStem (stem cells) NP001 NPT088 Oxaloacetate (OAA) PF PF Posiphen® Probucol Resveratrol RG6100 RGN1016 RO Salsalate S-Equol SUVN-G3031 T3D-959 TAK-071 Telmisartan TPI 287 UCMSC (stem cells) Venlafaxine Verubecestat Vorinostat VU319 As of 10/2017


Download ppt "Therapeutic Agents in Phase I Clinical Trials for Alzheimer’s Disease"

Similar presentations


Ads by Google